“…Recently, we identified a non-toxic Schiff base oxidovanadium(V) complex (N-(salicylideneaminato)-N -(2-hydroxyethyl)ethane-1,2-diamine) containing a hydrophobic and sterically hindered catecholate ligand (3,5-di-tert-butylcatecholato ligand) which is effective against several cancer cell types including glioma multiforme, an aggressive brain cancer (T98g), lung cancer cells (A549), pancreas cancer cells (PANC-1), cultured human bone cancer cells, breast cancer (MDA-MB-231), and human foreskin fibroblasts (HFF-1) [33,34,44,45]. Several catecholate ligands have been reported to be toxic [46][47][48] and, as a result, either more or less potent than their parent vanadium complexes [32,33]. In contrast to the parent catecholate, the sterically hindered catechol 3,5-di-tert-butylcatechol in a complex has been reported to be less toxic in female Swiss mice [45].…”